stability, and molecular interactions. It applies these models to support drug development workflows, including candidate screening, biomarker discovery, and patient stratification in oncology. Blank Bio also works on tools that convert complex RNA sequencing data into embeddings that can be used for downstream biomedical modeling and analysis. The company collaborates with pharmaceutical and research organizations to generate and utilize high-resolution RNA datasets for model training and evaluation. In addition, it develops benchmarks and computational frameworks that help standardize RNA-based machine learning research across different biological applications.